Not yet recruitingPhase 1NCT07075757

In Situ Injection of Anti-angiogenics in Patients With Brain Arteriovenous Malformations Not Eligible for Exclusion Treatment

Studying Brain arteriovenous malformation

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Frédéric Clarençon, Professor
Pitié-Salpêtrière Hospital, AP-HP - Neuroradiology department
Intervention
Single in situ intra-arterial injection of bevacizumab(drug)
Enrollment
20 enrolled
Eligibility
18-65 years · All sexes
Timeline
20252028

Study locations (5)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07075757 on ClinicalTrials.gov

Other trials for Brain arteriovenous malformation

Additional recruiting or active studies for the same condition.

See all trials for Brain arteriovenous malformation

← Back to all trials